Donepezil in schizophrenia - Is it helpful? An experimental design case study

Acta Psychiatrica Scandinavica

Volumn 104, Issue 6, 2001, Pages 469-472

  MacEwan, G W ^a   Ehmann, T S ^a   Khanbhai, I ^a   Wrixon, C ^b  

^a St Vincent's Hospital   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

Cognition; Donepezil; Research design; Schizophrenia

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; RISPERIDONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; HUMAN; MALE; METHODOLOGY; NEUROPSYCHOLOGICAL TEST; OUTPATIENT; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RATING SCALE; SCHIZOPHRENIA; SIDE EFFECT; TREATMENT OUTCOME; VERBAL BEHAVIOR;

EID: 0035216181     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0001-690x.2001.acp1c008d.x     Document Type: Article

References (12)

1. Cognitive functions of acetylcholine: Toward a unifying hypothesis
2. Effects of physostigmine on spatial attention in patients with progressive supranuclear palsy
3. Cortical acetylcholine, reality distortion, schizophrenia and lewy body dementia: Too much or too little cortical acetylcholine?
4. Antagonistic effects of physostigmine and methylphenidate in man
5. Cholinergic hyperactivity and negative symptoms: Behavioral effects of physostigmine in normal controls
6. Physostigmine: Effects on cognition and affect in normal subjects
7. Cholinergic stimulation alters performance and task specific regional cerebral blood flow during working memory
8. Cognitive function in manic depressives: Effects of lithium and physostigmine
9. Pharmacologic strategies for augmenting cognitive performance in schizophrenia
10. The effects of clozapine, risperidone and olanzapine on cognitive function in schizophrenia
11. Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring 'the right stuff'?
12. Donepezil in treatment-resistant bipolar disorder